Article Details
Retrieved on: 2021-03-03 19:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... study to assess the efficacy and safety of AMO-02, a dual action investigational mRNA modulating/GSK3ß kinase inhibitor, in the treatment of CDM1.
Article found on: www.prnewswire.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here